New combo aims to stall advanced breast cancer
NCT ID NCT01992952
First seen Jan 10, 2026 · Last updated May 15, 2026 · Updated 14 times
Summary
This study tests whether adding an experimental drug (AZD5363) to standard hormone therapy (fulvestrant) can help control advanced breast cancer in postmenopausal women. About 150 women whose cancer worsened on previous hormone therapy will receive either the combo or a placebo. The goal is to see if the combo delays cancer growth and to find the safest dose.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESTROGEN-RECEPTOR-POSITIVE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Blackpool Victoria Hospital
Blackpool, United Kingdom
-
Calderdale and Huddersfield NHS Foundation Trust
Huddersfield, United Kingdom
-
Christie Hospital
Manchester, Greater Manchester, United Kingdom
-
Clatterbridge Cancer Centre
Bebington, United Kingdom
-
Derriford Hospital
Plymouth, United Kingdom
-
Glan Clwyd Hospital
Rhyl, United Kingdom
-
Great Western General Hospital
Edinburgh, United Kingdom
-
Mount Vernon Cancer Centre
London, United Kingdom
-
Queen's Hospital
Romford, United Kingdom
-
Royal Albert and Edward Infirmary -Wrightington
Wigan, United Kingdom
-
Royal Blackburn Hospital
Blackburn, United Kingdom
-
Royal Free Hospital
London, United Kingdom
-
Royal Preston Hospital
Preston, United Kingdom
-
Royal Stoke University Hospital
Stoke-on-Trent, United Kingdom
-
Southampton General Hospital
Southampton, United Kingdom
-
St James's University Hospital
Leeds, United Kingdom
-
The Ipswich Hospital NHS Trust
Ipswich, United Kingdom
-
University Hospital of North Durham
Durham, United Kingdom
-
University Hospitals Morecambe Bay
Lancaster, United Kingdom
-
Velindre NHS Trust
Cardiff, Cardiff, United Kingdom
-
Ysbyty Gwynedd
Bangor, United Kingdom
Conditions
Explore the condition pages connected to this study.